| Target Price | $430.95 |
| Price | $374.41 |
| Potential | 15.10% |
| Number of Estimates | 44 |
| 44 Analysts have issued a price target Tesla 2027 . The average Tesla target price is $430.95. This is 15.10% higher than the current stock price. The highest price target is $577.50 54.24% , the lowest is $25.11 93.29% . | |
| A rating was issued by 54 analysts: 29 Analysts recommend Tesla to buy, 23 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Tesla stock has an average upside potential 2027 of 15.10% . Most analysts recommend the Tesla stock at Purchase. |
52 Analysts have issued a sales forecast Tesla 2026 . The average Tesla sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
40 Analysts have issued an Tesla EBITDA forecast 2026. The average Tesla EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
53 Tesla Analysts have issued a net profit forecast 2026. The average Tesla net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| GLJ Research |
Sell
➜
Sell
|
Unchanged | Nov 13 2026 |
| GLJ Research |
Sell
➜
Sell
|
Unchanged | Nov 05 2026 |
| Barclays |
Equal-Weight
➜
Overweight
|
Upgrade | Oct 26 2026 |
| BNP Paribas |
Underperform
➜
Neutral
|
Upgrade | Oct 22 2026 |
| GLJ Research |
Sell
➜
Sell
|
Unchanged | Oct 22 2026 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Oct 22 2026 |
| Canaccord Genuity |
Buy
➜
Buy
|
Unchanged | Oct 22 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
GLJ Research:
Sell
➜
Sell
|
Nov 13 2026 |
|
Unchanged
GLJ Research:
Sell
➜
Sell
|
Nov 05 2026 |
|
Upgrade
Barclays:
Equal-Weight
➜
Overweight
|
Oct 26 2026 |
|
Upgrade
BNP Paribas:
Underperform
➜
Neutral
|
Oct 22 2026 |
|
Unchanged
GLJ Research:
Sell
➜
Sell
|
Oct 22 2026 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Oct 22 2026 |
|
Unchanged
Canaccord Genuity:
Buy
➜
Buy
|
Oct 22 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


